Form 10-Q ORGANOVO HOLDINGS, INC. For: Dec 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Form 10-Q ORGANOVO HOLDINGS, INC. For: Dec 31

Organovo (ONVO) Reports In-Line Q3 Loss of 9c/Share

February 9, 2015 8:09 AM EST

Organovo (AMEX: ONVO) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $155 thousand versus the consensus estimate of $155 thousand.

Keith Murphy, chairman and chief executive officer of Organovo, commented on the results, "Organovo has had a successful launch of its exVive3D Human Liver Tissue, and customer response continues to be strong. Our contracted customers include companies from among the top 25 global pharma companies, smaller public pharma companies, and private venture-backed pharma companies. Conversion of potential customers, those requesting quotes, to... More